BRAF mutation predicts sensitivity to MEK inhibition

David B. Solit(Memorial Sloan Kettering Cancer Center), Levi A. Garraway(Broad Institute), Christine A. Pratilas(Memorial Sloan Kettering Cancer Center), Ayana Sawai(Memorial Sloan Kettering Cancer Center), Gad Getz(Broad Institute), Andrea Basso(Memorial Sloan Kettering Cancer Center), Qing Ye(Memorial Sloan Kettering Cancer Center), Jose Lobo(Memorial Sloan Kettering Cancer Center), Yuhong She(Memorial Sloan Kettering Cancer Center), Iman Osman(University Medical Center), Todd R. Golub(Dana-Farber Cancer Institute), Judith S. Sebolt–Leopold(Pfizer (United States)), William R. Sellers(Broad Institute), Neal Rosen(Memorial Sloan Kettering Cancer Center)
Nature
November 6, 2005
10.1038/nature04304
Cited by 1,326Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis